Chemicals
CIRS Group
Chemicals
Cosmetic
Food
Medical Devices
Agrochemicals
CIRS Testing
Carbon Neutrality
Search

ECHA Releases 2025-2027 Substance Evaluation Rolling Plan (CoRAP), 28 Substances Listed

from CIRS by

On March 25, 2025, the European Chemicals Agency (ECHA) officially published an updated version of the Community Rolling Action Plan (CoRAP) for 2025-2027. The plan aims to systematically evaluate 28 chemical substances that may pose risks to human health or the environment under Articles 44–48 of the EU REACH Regulation ((EC) No 1907/2006). The evaluations will be led by competent authorities of 8 Member States and span 2025 to 2027.

EU,CoRAP,Substance,Evaluation 2025,Chemical,REACH

Highlights of the Plan

1. New and Extended Evaluations

  • 13 new substances have been added to the evaluation list for the first time, focusing on their potential risks.
  • 18 substances are carried over from the CoRAP 2024-2026 Update published in March 2024, with 12 substances postponed to post-2025 due to pending supplementary data submissions (dossier evaluation requests) from companies.

2. Evaluation Timeline

  • 2025: 8 substances (including 2 grouped analogues) begin evaluation.
  • 2026: 15 substances enter the evaluation process.
  • 2027: 5 substances start evaluation.

Note: The lists for 2026 and 2027 may be adjusted in future CoRAP updates.

3. 3 Substances Withdrawn

  • The first substance was withdrawn as existing data sufficiently addressed initial concerns.
  • For the second substance, additional requirements were raised through dossier evaluation. If unresolved, it may be relisted in CoRAP.
  • The third substance (Reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives) has been formally classified as a Substance of Very High Concern (SVHC) and will undergo stricter regulatory controls.

Newly Added and Withdrawn Substances

Year

EC/List Number

CAS Number

Substance Public Name

Initial grounds for concern

2025

201-116-6

78-42-2

Tris(2-ethylhexyl)

phosphate

suspected C, potential endocrine disruptor, wide dispersive use, consumer use, exposure of workers, and environmental exposure.

2025

201-114-5

78-40-0

Triethyl phosphate

suspected C, suspected M, suspected R, potential endocrine disruptor wide dispersive use, consumer use, exposure of workers, environmental exposure, and high (aggregated) tonnages.

2025

265-929-8

65799-47-5

[3-(2,3

epoxypropoxy)propyl]dime

 thoxymethylsilane

suspected M

exposure of workers 

2025

220-780-8

2897-60-1

[3-(2,3

epoxypropoxy)propyl]dieth

 oxymethylsilane

suspected M

exposure of workers 

2025

208-047-0

506-61-6

Potassium

dicyanoargentate

suspected R, potential endocrine disruptor, other suspected human health hazard, wide dispersive use exposure of workers, and environmental exposure.

2026

238-098-4

14228-73-0

1,4-bis[(2,3

epoxypropoxy)methyl]cycl

 ohexane

suspected M, wide dispersive use, consumer use, and exposure of workers.

2026

203-183-7

104-19-8

N,N,4-trimethylpiperazine-

1-ethylamine

suspected R, other hazard based concerns, wide dispersive use, and exposure of workers.

2026

201-148-0

78-83-1

2-methylpropan-1-ol

suspected R, other hazard based concerns, wide dispersive use consumer use, exposure of workers, exposure of sensitive populations, environmental exposure, and high (aggregated) tonnage.

2026

407-000-3

127519-17-9

A mixture of branched and

linear C7-C9 alkyl 3-[3

(2H-benzotriazol-2-yl)-5

(1,1-dimethylethyl)-4

hydroxyphenyl]propionates

suspected PMT/vPvM, wide dispersive use, and environmental exposure.

2026

400-830-7

-

A mixture of: a-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl

?-hydroxypoly(oxyethylene);

a-3-(3-(2H-benzotriazol-2

yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-?-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene)

suspected PMT/vPvM, wide dispersive use, and environmental exposure.

2026

400-820-2

84268-33-7

Methyl 3-[3-(2H-benzotriazol-2-yl)-4-hydroxy-5-(2-methyl-2-propanyl)phenyl]propanoate

suspected PMT/vPvM, wide dispersive use, and environmental exposure.

2026

916-914-6

-

Reaction mass of Octyl-3-[3-tert-butyl-4-hydroxy-5-(5-chloro-2H-benzotriazole-2-yl)phenyl]propionate and 2-Ethylhexyl-3-[3-tert-butyl-4-hydroxy-5-(5-chloro-2H-benzotriazole-2-yl)phenyl]propionate

suspected PMT/vPvM, wide dispersive use, and environmental exposure.

2026

confidential

-

Di-substituted tert-alkyl 3- [3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl]propanoate

suspected PMT/vPvM, wide dispersive use, and environmental exposure.

Withdr awn

202-860-4

100-52-7

Benzaldehyde

suspected M, wide dispersive use, consumer use, and exposure of workers.

Withdr awn

205-739-4

149-44-0

Sodium hydroxymethanesulphinate

suspected C, suspected M, suspected R, wide dispersive use, exposure of workers, and high (aggregated) tonnage.

Withdr awn

421-820-9

192268-65-8

Reaction mass of:

triphenylthiophosphate and

tertiary butylated phenyl

derivatives

suspected PBT/vPvB

About CIRS

CIRS Group is a leading provider of comprehensive regulatory compliance services and solutions for chemicals, cosmetics, food and food-related products, agrochemicals, and medical devices. Its chemical team consists of experts with extensive knowledge in chemistry, toxicology, environmental science, and related fields. They are well-versed in various international regulations, including but not limited to EU REACH, CLP, GHS, TSCA, and K-REACH. Our chemical compliance services in the EU cover:

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Further Information

ECHA

  

We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.

0:00
/
0:00
加载完毕: 0%
进度: 0%
媒体流类型直播
0:00
 
file ID:
request ID:
media type:
mime type:
provider:
resolution:
rate:
frames:
buffer:
connection speed:
info:
[X]
Contact Us
+353 1 477 3710 (EU)
+44 20 3239 9430 (UK)
+1 703 520 1420 (USA)
+86 571 8720 6574 (CN)
+82 2 6347 8816 (KR)
+81 070-9365-8022 (JP)